Pharmacovigilance USA 2025

Website https://usa-canada.virtueinsight.com/event/pharmacovigilance-usa-2025/ | Edit Freely

Category pharma

Deadline: May 06, 2025 | Date: May 07, 2025-May 08, 2025

Venue/Country: The Inn at Longwood Medical, Boston, Massachusetts, U.S.A

Updated: 2025-03-27 11:43:32 (GMT+9)

Call For Papers - CFP

“Ensuring safer drugs to market. Latest developments in PV”

07th & 8th May 2025, The Inn at Longwood Medical, Boston, Massachusetts, USA

38th Pharmacovigilance USA 2025 will bring together top pharmaceutical, biotechnology and regulatory, vendor representatives under one roof that will address the key issues of the industry. Get more from the event, with a broader scope bringing the whole communications value chain together.

Please contact me for Sponsor / Exhibit / Booth / Delegate at E-mail - kavithavirtueinsight.co.in or Call - +44 20 3509 3779

SPONSORS:

Gold Sponsors: Cencora, Arisglobal

Silver Sponsors: Veeva Systems, HMGlobal Pharmacovigilance Consulting

We have more sponsorship opportunities available for the event, which gives you an opportunity to exhibit/booth/speak and create brand awareness. Please email to kavithavirtueinsight.co.in for more details.

DELEGATE REGISTRATION:

Registration for this conference through any third party site will involve VAT or TAX. If you would like to register without Tax please register through site

https://virtueinsight.com/event/pharmacovigilance-usa-2025/

Super Early Bird Price (Valid Till 11th March 2024)

01 Delegate - $999

4 Delegates for the price of 2 - $1998

Early Bird Price (Valid till 12th March 2024 -11th April 2024)

01 Delegate - $1100

4 Delegates for the price of 2 - $2200

Standard Price (From 12th April 2024)

01 Delegate - $1599

4 Delegates for the price of 2 - $3198

KEY SPEAKERS:

• KHAUDEJA BANO, VP - Global Head of Device Quality, Roche - Genentech

• MARIETTE BOERSTOEL-STREEFLAND, SVP, Worldwide Patient Safety Officer, Bristol-Myers Squibb

• MILIND SARDESA, Senior Director, Safety Surveillance, Global Patient Safety, Novo Nordisk

• NINA KOLA, VP, Head Medical Safety Assessment Hematology and Oncology, Bristol-Myers Squibb

• DANYTZA WARD, Executive Director, Head of PV Operations & Global Risk Management, Jazz Pharmaceuticals

• CARMIT STRAUSS, Executive Director, Head of Risk Management and Organ Toxicity, Takeda Pharmaceuticals

• E. ALTON SARTOR, Medical Director, Patient Safety Physician Digital & Devices, AstraZeneca

• JESSICA CHINAULT-JALBOOT, Exec Dir, Regulatory and PV Compliance, Jazz Pharmaceuticals

• KARTHIK MUTHUSAMI, Head of Expedited Safety Reporting, Bristol-Myers Squibb

• WILLIAM A. BLUMENTALS, Head of Pharmacoepidemiology, Specialty Care, Sanofi

• SHARON REID, Director of Risk Management Center of Excellence, Pfizer

• KSHITIJA BAPAT, Dir, Compliance Operations, Jazz Pharmaceuticals

• VIKALP KHARE, Director, Otsuka Pharmaceutical

• BEENA WOOD, Head of Innovation & Technology, CSL Behring

• REEM YASIN, Quality Assurance & PV Manager, Hawkary Pharmaceuticals (Iraq)

• ABBEY GOW, QA & Deviation Management Expert, Sanofi

• SIVA KUMAR BUDDHA, Director - PV (Head of Signal & Risk Management), Indegene

• ANKA EHRHARDT, Director, Cell-Based Assays / Analytical Research & Development, Merck

• JASON BRYANT, VP Data & AI, ArisGlobal

• KARTHIK BABU, CHC Global PV Operations Head, Sanofi

• HEATHER LEIGH FLANNERY, CEO & Co-Founder, AI MINDSystems Foundation

• ASHISH JAIN, Sr, Director, Clinical Safety & Pharmacovigilance, Curis

• MEERA NAGARIA, Senior Data Scientist, Johnson & Johnson

• KAPIL BHUTADA, Head of PV Safety Operation & Compliance, Asklepios BioPharmaceutical

• HEATHER MURPHY, Founder and CEO, HMGlobal Pharmacovigilance Consulting

• BEN LOCWIN, VP, Project Solutions, Black Diamond Networks

Plus more joining soon

FOCUS AREAS:

• Market Trends - Critique & Ways Forward

• Challenges / Opportunities

• Patient Safety / Patient Centricity

• Impact of Technology - AI, ML, DA

• RMP / REMS

• Quality, Safety & Signal Detection

• Automation in PV

• Regulatory

• Audits & Inspection

• RWE / RWD

• Outsourcing

WHO SHOULD ATTEND:

CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:

Pharmacovigilance, Pharmacoepidemiology, Pharmacogenomics, Drug/Product Safety, Drug Development, Information and Clinical Data Management, Clinical Pharmacology, Clinical Safety, Periodical safety update Reports, Risk Management, Research & Development, Quality Assurance, Patient Safety, Signal Detection, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information technology, Sales and Marketing.

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, and meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies at the high-levelconference.